WALANT Technique (Wide Awake Local Anesthesia No Tourniquet) for Carpal Tunnel Release.
Launched by CMC AMBROISE PARÉ · Jul 28, 2020
Trial Information
Current as of May 13, 2025
Completed
Keywords
ClinConnect Summary
This is a multicenter, prospective, randomized, open-label study assessing the interest of the association of the WALANT local infiltration technique with analgesic troncular blocks (TRONC) at the wrist, for the endoscopic CTR.
This study compares two groups:
* CONTROL group (usual technique) : TRONC (using a long-acting LA : Ropivacaine) + Tourniquet
* WALANT group (experimental technique) : TRONC (using a long-acting LA : Ropivacaine) + WALANT ( using a short-term LA : Lidocaine + epinephrine)
RA procedures will be systematically performed under ultrasound guidance, 45 min befor surger...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing endoscopic carpal tunnel release
- • Consent for participation
- • Affiliation to a social security system
- Exclusion Criteria:
- • Chronic pain syndrome or fibromyalgia
- • Contraindication for locoregional anesthesia
- • ASA 4
- • Pregnant or breastfeeding women
- • Patients under protection of the adults(guardianship, curators or safeguard of justice)
- • Communication difficulties or neuropsychiatric disorder
About Cmc Ambroise Paré
CMC Ambroise Paré is a distinguished clinical trial sponsor dedicated to advancing medical research and innovation. With a focus on enhancing patient care, the organization specializes in the development and management of clinical trials across various therapeutic areas. CMC Ambroise Paré is committed to rigorous scientific standards, ensuring compliance with regulatory requirements while fostering collaboration among healthcare professionals, researchers, and stakeholders. By leveraging cutting-edge methodologies and a patient-centric approach, the organization aims to contribute to the development of safe and effective treatments, ultimately improving health outcomes and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, Ile De France, France
Paris, Ile De France, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials